Cargando…

Delineating the Association Between Soluble CD26 and Autoantibodies Against G-Protein Coupled Receptors, Immunological and Cardiovascular Parameters Identifies Distinct Patterns in Post-Infectious vs. Non-Infection-Triggered Myalgic Encephalomyelitis/Chronic Fatigue Syndrome

Soluble cluster of differentiation 26 (sCD26) has a wide range of enzymatic functions affecting immunological, metabolic and vascular regulation. Diminished sCD26 concentrations have been reported in various autoimmune diseases and also in Myalgic Encephalomyelitis/Chronic fatigue syndrome (ME/CFS)....

Descripción completa

Detalles Bibliográficos
Autores principales:	Szklarski, Marvin, Freitag, Helma, Lorenz, Sebastian, Becker, Sonya C., Sotzny, Franziska, Bauer, Sandra, Hartwig, Jelka, Heidecke, Harald, Wittke, Kirsten, Kedor, Claudia, Hanitsch, Leif G., Grabowski, Patricia, Sepúlveda, Nuno, Scheibenbogen, Carmen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8056217/ https://www.ncbi.nlm.nih.gov/pubmed/33889154 http://dx.doi.org/10.3389/fimmu.2021.644548

Ejemplares similares

Autoantibodies to Vasoregulative G-Protein-Coupled Receptors Correlate with Symptom Severity, Autonomic Dysfunction and Disability in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome
por: Freitag, Helma, et al.
Publicado: (2021)

Peripheral endothelial dysfunction in myalgic encephalomyelitis/chronic fatigue syndrome
por: Scherbakov, Nadja, et al.
Publicado: (2020)

Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: Efficacy of Repeat Immunoadsorption
por: Tölle, Markus, et al.
Publicado: (2020)

Tolerability and Efficacy of s.c. IgG Self-Treatment in ME/CFS Patients with IgG/IgG Subclass Deficiency: A Proof-of-Concept Study
por: Scheibenbogen, Carmen, et al.
Publicado: (2021)

Endothelial dysfunction and altered endothelial biomarkers in patients with post-COVID-19 syndrome and chronic fatigue syndrome (ME/CFS)
por: Haffke, Milan, et al.
Publicado: (2022)

Observational Study of Repeat Immunoadsorption (RIA) in Post-COVID ME/CFS Patients with Elevated ß2-Adrenergic Receptor Autoantibodies—An Interim Report
por: Stein, Elisa, et al.
Publicado: (2023)

The SARS-CoV-2 receptor angiotensin-converting enzyme 2 (ACE2) in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: analysis of high-throughput epigenetic and gene expression studies
por: Malato, João, et al.
Publicado: (2021)

The expression signature of very long non-coding RNA in myalgic encephalomyelitis/chronic fatigue syndrome
por: Yang, Chin-An, et al.
Publicado: (2018)

Hand grip strength and fatigability: correlation with clinical parameters and diagnostic suitability in ME/CFS
por: Jäkel, Bianka, et al.
Publicado: (2021)

Autoantibodies to beta-adrenergic and muscarinic cholinergic receptors in Myalgic Encephalomyelitis (ME) patients – A validation study in plasma and cerebrospinal fluid from two Swedish cohorts
por: Bynke, Annie, et al.
Publicado: (2020)

The SARS-CoV-2 receptor angiotensin-converting enzyme 2 (ACE2) in myalgic encephalomyelitis/chronic fatigue syndrome: A meta-analysis of public DNA methylation and gene expression data
por: Malato, João, et al.
Publicado: (2021)

IgG stimulated β2 adrenergic receptor activation is attenuated in patients with ME/CFS
por: Hartwig, Jelka, et al.
Publicado: (2020)

Autoimmunity-Related Risk Variants in PTPN22 and CTLA4 Are Associated With ME/CFS With Infectious Onset
por: Steiner, Sophie, et al.
Publicado: (2020)

Evaluation of a Webinar to Increase Health Professionals’ Knowledge about Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)
por: Froehlich, Laura, et al.
Publicado: (2023)

Dysregulated autoantibodies targeting vaso- and immunoregulatory receptors in Post COVID Syndrome correlate with symptom severity
por: Sotzny, Franziska, et al.
Publicado: (2022)

Revisiting IgG Antibody Reactivity to Epstein-Barr Virus in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome and Its Potential Application to Disease Diagnosis
por: Sepúlveda, Nuno, et al.
Publicado: (2022)

An attempt to explain the neurological symptoms of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome
por: Wirth, Klaus J., et al.
Publicado: (2021)

Correction to: An attempt to explain the neurological symptoms of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome
por: Wirth, Klaus J., et al.
Publicado: (2022)

Pathophysiology of skeletal muscle disturbances in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)
por: Wirth, Klaus J., et al.
Publicado: (2021)

Editorial: Current Insights Into Complex Post-infection Fatigue Syndromes With Unknown Aetiology: The Case of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome and Beyond
por: Westermeier, Francisco, et al.
Publicado: (2022)

Causal attributions and perceived stigma for myalgic encephalomyelitis/chronic fatigue syndrome
por: Froehlich, Laura, et al.
Publicado: (2021)

Muscle sodium content in patients with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome
por: Petter, Elisabeth, et al.
Publicado: (2022)

Correction: Muscle sodium content in patients with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome
por: Petter, Elisabeth, et al.
Publicado: (2023)

The Gut Microbiome in Myalgic Encephalomyelitis (ME)/Chronic Fatigue Syndrome (CFS)
por: König, Rahel S., et al.
Publicado: (2022)

Medical Care Situation of People with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome in Germany
por: Froehlich, Laura, et al.
Publicado: (2021)

Author Correction: A prospective observational study of post-COVID-19 chronic fatigue syndrome following the first pandemic wave in Germany and biomarkers associated with symptom severity
por: Kedor, Claudia, et al.
Publicado: (2022)

A prospective observational study of post-COVID-19 chronic fatigue syndrome following the first pandemic wave in Germany and biomarkers associated with symptom severity
por: Kedor, Claudia, et al.
Publicado: (2022)

Chronic viral infections in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS)
por: Rasa, Santa, et al.
Publicado: (2018)

Myalgic Encephalomyelitis: Symptoms and Biomarkers
por: Jason, Leonard A., et al.
Publicado: (2015)

Autoantibody Correlation Signatures in Fibromyalgia and Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: Association with Symptom Severity
por: Ryabkova, Varvara A., et al.
Publicado: (2023)

The prevalence of chronic fatigue syndrome/ myalgic encephalomyelitis: a meta-analysis
por: Johnston, Samantha, et al.
Publicado: (2013)

Epidemiological characteristics of chronic fatigue syndrome/myalgic encephalomyelitis in Australian patients
por: Johnston, Samantha C, et al.
Publicado: (2016)

Alteration of Cortical Volume and Thickness in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome
por: Thapaliya, Kiran, et al.
Publicado: (2022)

Metformin Attenuates ROS via FOXO3 Activation in Immune Cells
por: Hartwig, Jelka, et al.
Publicado: (2021)

Herpesviruses Serology Distinguishes Different Subgroups of Patients From the United Kingdom Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Biobank
por: Domingues, Tiago Dias, et al.
Publicado: (2021)

Impact of Misdiagnosis in Case-Control Studies of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome
por: Malato, João, et al.
Publicado: (2023)

The Economic Impacts of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome in an Australian Cohort
por: Close, Shara, et al.
Publicado: (2020)

Systematic Review of Sleep Characteristics in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome
por: Maksoud, Rebekah, et al.
Publicado: (2021)

Myalgic encephalomyelitis: International Consensus Criteria
por: Carruthers, B M, et al.
Publicado: (2011)

Medical School Education on Myalgic Encephalomyelitis
por: Muirhead, Nina, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_r83dpkv3age56uj9i371mrkmpi